These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 20385369)
1. Typical carcinoids and neuroendocrine carcinomas of the stomach: differing clinical courses and prognoses. Kim BS; Oh ST; Yook JH; Kim KC; Kim MG; Jeong JW; Kim BS Am J Surg; 2010 Sep; 200(3):328-33. PubMed ID: 20385369 [TBL] [Abstract][Full Text] [Related]
2. [Clinicopathological features and prognosis of different gastric carcinoid subtypes]. Liang JW; Zhou ZX; Liu Q; Bai XF; Zhao P Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):866-9. PubMed ID: 19173835 [TBL] [Abstract][Full Text] [Related]
3. [Neuroendocrine gastric carcinoma. A case report and review of current management]. Mondragón-Sánchez A; Mondragón-Sánchez R; Bernal Maldonado R; Baquera-Heredia J; Gómez-Gómez E Rev Gastroenterol Mex; 2003; 68(2):129-32. PubMed ID: 15127650 [TBL] [Abstract][Full Text] [Related]
4. [Carcinoid tumors and neuroendocrine carcinomas of the stomach. Prognosis and therapeutic management. Study of 6 cases]. Moreaux J; Martin E; Saliou C Ann Chir; 1997; 51(2):121-9. PubMed ID: 9297867 [TBL] [Abstract][Full Text] [Related]
5. [Neuroendocrine tumors of the stomach. Surgery therapy and prognosis]. Bektas H; Länger F; Piso P; Werner U; Musholt TJ; Lehner F; Becker T; Klempnauer J Chirurg; 2002 Apr; 73(4):331-5. PubMed ID: 12063917 [TBL] [Abstract][Full Text] [Related]
6. Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems? Scherübl H; Cadiot G; Jensen RT; Rösch T; Stölzel U; Klöppel G Endoscopy; 2010 Aug; 42(8):664-71. PubMed ID: 20669078 [TBL] [Abstract][Full Text] [Related]
7. [Neuroendocrine tumors of the lung]. Oliaro A; Donati G; Filosso PL; Ruffini E Minerva Chir; 2000; 55(1-2):7-16. PubMed ID: 10832278 [TBL] [Abstract][Full Text] [Related]
9. Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type. Borch K; Ahrén B; Ahlman H; Falkmer S; Granérus G; Grimelius L Ann Surg; 2005 Jul; 242(1):64-73. PubMed ID: 15973103 [TBL] [Abstract][Full Text] [Related]
10. Total gastrectomy for type 1 gastric carcinoid: an unusual surgical indication? Clemente G; Sarno G; Giordano M; De Rose AM; Giovannini I; Vecchio FM; Nuzzo G Minerva Chir; 2007 Oct; 62(5):421-4. PubMed ID: 17947953 [TBL] [Abstract][Full Text] [Related]
11. Bronchial carcinoid tumors: nodal status and long-term survival after resection. Cardillo G; Sera F; Di Martino M; Graziano P; Giunti R; Carbone L; Facciolo F; Martelli M Ann Thorac Surg; 2004 May; 77(5):1781-5. PubMed ID: 15111186 [TBL] [Abstract][Full Text] [Related]
12. Management and clinical outcomes of type I gastric carcinoid patients: retrospective, multicenter study in Japan. Sato Y; Imamura H; Kaizaki Y; Koizumi W; Ishido K; Kurahara K; Suzuki H; Fujisaki J; Hirakawa K; Hosokawa O; Ito M; Kaminishi M; Furuta T; Chiba T; Haruma K Dig Endosc; 2014 May; 26(3):377-84. PubMed ID: 24188531 [TBL] [Abstract][Full Text] [Related]
13. Usefulness of laparoscope-assisted antrectomy for gastric carcinoids with hypergastrinemia. Hoshino M; Omura N; Yano F; Tsuboi K; Matsumoto A; Yamamoto SR; Akimoto S; Kashiwagi H; Yanaga K Hepatogastroenterology; 2010; 57(98):379-82. PubMed ID: 20583448 [TBL] [Abstract][Full Text] [Related]
14. Gastric carcinoids in patients with hypergastrinemia. Jordan PH; Barroso A; Sweeney J J Am Coll Surg; 2004 Oct; 199(4):552-5. PubMed ID: 15454137 [TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic features of neuroendocrine carcinomas of the stomach: appraisal of small cell and large cell variants. Matsui K; Jin XM; Kitagawa M; Miwa A Arch Pathol Lab Med; 1998 Nov; 122(11):1010-7. PubMed ID: 9822131 [TBL] [Abstract][Full Text] [Related]
16. [Mixed exocrine-endocrine gastric carcinoma: a rarity of little consequence?]. Sauer J; Hinze R; Dommisch K Dtsch Med Wochenschr; 2007 Oct; 132(40):2077-80. PubMed ID: 17899502 [TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity in 11q13-14 regions in gastric neuroendocrine tumors not associated with multiple endocrine neoplasia type 1 syndrome. D'Adda T; Keller G; Bordi C; Höfler H Lab Invest; 1999 Jun; 79(6):671-7. PubMed ID: 10378509 [TBL] [Abstract][Full Text] [Related]
18. Thymic neuroendocrine carcinomas with combined features ranging from well-differentiated (carcinoid) to small cell carcinoma. A clinicopathologic and immunohistochemical study of 11 cases. Moran CA; Suster S Am J Clin Pathol; 2000 Mar; 113(3):345-50. PubMed ID: 10705813 [TBL] [Abstract][Full Text] [Related]
19. Endocrine tumours of the stomach. Delle Fave G; Capurso G; Milione M; Panzuto F Best Pract Res Clin Gastroenterol; 2005 Oct; 19(5):659-73. PubMed ID: 16253892 [TBL] [Abstract][Full Text] [Related]
20. Gastric neuroendocrine carcinoma: clinicopathologic review and immunohistochemical study of E-cadherin and Ki-67 as prognostic markers. Boo YJ; Park SS; Kim JH; Mok YJ; Kim SJ; Kim CS J Surg Oncol; 2007 Feb; 95(2):110-7. PubMed ID: 17066436 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]